Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

Hims and Hers Health beat Wall Street estimates for third-quarter revenue on Monday, as the telehealth company added ...

In June, Novo ended a partnership with Hims & Hers that provided access to Wegovy through the pharma's Novocare Pharmacy because Hims & Hers was trying to skirt legal restrictions on compounding ...

Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO ...

Molecule is claimed to be made from "natural ingredients" such as dandelion root and fennel seed, but investigations tell a different story ...

On behalf of our sponsors at Tonum Health, we're leaning about the millions of Americans using weight loss medications like Ozempic and Wegovy. There's now a growing conversation around what happens ...

The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments ...

Revenue rose 49% year-over-year to nearly $600 million, while net income reached $15.8 million and adjusted EBITDA climbed 53 ...

New survey data shows 37 percent of US adults are currently classed as obese, down from a record high of 39.9 percent in 2022 ...

After filing one lawsuit to try to block Novo Nordisk's $9 billion effort to trump the takeover, Pfizer has returned to the ...

For many employees, it can be hard to feel connected to their company, especially at huge corporations like Walmart. But in ...